European private equity firm Andera Partners announced that it has co-led the Series A financing round of Adcytherix, a ...

Chicago, USA-based biotech EVOQ Therapeutics has announced a collaboration and license agreement with French pharma major ...

For two decades, US biotech Vertex (Nasdaq: VRTX) built a reputation as one of the few companies to pair cutting-edge science ...

Chinese biotech Xuanzhu Biopharmaceutical (2575.HK) has raised over HK$780 million ($100 million) through its debut on the ...

Los Angeles, USA-based biotech Pelage Pharmaceuticals has announced the close of a $120 million Series B financing.

German biotech Tubulis has closed a 308 million euro ($361 million) series C financing, marking the largest round of its kind ...

California start-up Graph AI has raised $3 million in a seed round led by Bessemer Venture Partners, with the cash to ...

Sino-American oncology specialist BeOne Medicines has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for sonrotoclax, a potentially best-in ...

Eli Lilly is maintaining its momentum in diabetes and weight loss, presenting impressive data beyond its big-selling dual GLP-1/GIP receptor agonist Mounjaro (tirzepatide).

The USA’s 340B hospital markup program is costing taxpayers an estimated $13.4 billion a year in lost Medicare rebates, according to a new report from Berkeley Research Group (BRG).